Publications
Journals
- HIV-CAUSAL Collaboration. (2012). Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis. 2012 May;54(9):1364-72. Epub 2012 Mar 28. Publisher weblink.
- HIV-CAUSAL Collaboration; Cain LE; Logan R; Robins JM; et al. (2011). When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med. 2011 Apr 19;154(8):509-15. Publisher weblink.
- HIV CC. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (London, England). 24:123-137-123-137. Publisher weblink.
- Burney P; Potts J; Makowska J; Kowalski M; Phillips J; Gnatiuc L; Shaheen S; Joos G; et alVan Cauwenberge P; van Zele T; Verbruggen K; van Durme Y; Derudder I; Wohrl S; Godnic-Cvar J; Salameh B; Skadhauge L; Thomsen G; Zuberbier T; Bergmann KC; Heinzerling L; Renz H; Al-Fakhri N; Kosche B; Hildenberg A; Papadopoulos NG; Xepapadaki P; Zannikos K; Gjomarkaj M; Bruno A; Pace E; Bonini S; Bresciani M; Gramiccioni C; Fokkens W; Weersink EJM; Carlsen K-H; Bakkeheim E; Loureiro C; Villanueva CM; Sanjuas C; Zock J-P; Lundback B; Janson C. (1 Dec 2008). A case-control study of the relation between plasma selenium and asthma in European populations: a GA(2)LEN project. ALLERGY. 63:1647-1647. Author weblink DOI.
- Shaheen S; Potts J; Gnatiuc L; Makowska J; Kowalski ML; Joos G; van Zele T; van Durme Y; et alDe Rudder I; Wöhrl S; Godnic-Cvar J; Skadhauge L; Thomsen G; Zuberbier T; Bergmann KC; Heinzerling L; Gjomarkaj M; Bruno A; Pace E; Bonini S; Fokkens W; Weersink EJ; Loureiro C; Todo-Bom A; Villanueva CM; Sanjuas C; Zock JP; Janson C; Burney P; Selenium and Asthma Research Integration project; GA2LEN. (Nov 2008). The relation between paracetamol use and asthma: a GA2LEN European case-control study. Eur Respir J. 32:1231-1236. DOI.
Conferences
- Gnatiuc L; Coton S; Buist S; Kato B; Mejza P; Burney P. RISK FACTORS FOR RESPIRATORY EXACERBATIONS IN THE BOLD STUDY. Winter Meeting of the British-Thoracic-Society, 7 Dec 2011 - 9 Dec 2011. 66:A152-A152. B M J PUBLISHING GROUP (1 Dec 2011). Author weblink DOI.
- Gnatiuc L; Buist S; Kato B; Burney P. The treatment gap for “essential respiratory medications” in low and middle income countries. 42nd Union World Conference on Lung Health. (2011).
- Gnatiuc L; Kato B; Coton S; Buist S; Burney P. Medication and preventive measures for COPD in the BOLD study. European Respiratory Society. (2011).
- Lamprecht B; Studnicka M; McBurnie M; Allison M; Vollmer WM; Nastalek P; Nielsen R; Tan WC; et alGnatiuc L; Buist AS. Gender-related Differences In Respiratory Symptoms: Results From The International BOLD Study. American Thoracic Society. (May 2010). Author weblink.
- Gnatiuc L; Newson RB; Jarvis DL. Asthma, Puberty and BMI in the 1958 British Birth Cohort. BRITISH THORACIC SOCIETY, 2010. Publisher weblink.
- Millington KA; Gnatiuc L; Seneviratne S; Kon OM; Wickramasinge M; Han LY. TIGRAs and challenges on the diagnosis of latent TB infection. International Symposium “Methods for Evaluating Medical Tests”, Birmingham. (Jul 2008). Author weblink.


